These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
221 related items for PubMed ID: 1469603
1. [Studies on as-triazine derivatives. XVIII. Synthesis of 5,6-diaryl-1,2,4-triazine derivatives as blood platelet aggregation inhibitors]. Konno S, Kokubo T, Amano M, Yoshida N, Sagi M, Yamanaka H. Yakugaku Zasshi; 1992 Oct; 112(10):729-41. PubMed ID: 1469603 [Abstract] [Full Text] [Related]
7. Synthesis and anti-platelet activity of obovatol derivatives. Kwak JH, Lee S, Park ES, In JK, Song J, Kim YJ, Choi NS, Lee H, Yun YP, Hong JT, Kwak YS, Min KH, Jung JK. Arch Pharm Res; 2011 Jul; 34(7):1107-12. PubMed ID: 21811917 [Abstract] [Full Text] [Related]
11. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives. Zhao LM, Jin HS, Sun LP, Piao HR, Quan ZS. Bioorg Med Chem Lett; 2005 Nov 15; 15(22):5027-9. PubMed ID: 16169724 [Abstract] [Full Text] [Related]
12. Synthesis and in vitro anticancer evaluation of some 4,6-diamino-1,3,5-triazine-2-carbohydrazides as Rad6 ubiquitin conjugating enzyme inhibitors. Kothayer H, Spencer SM, Tripathi K, Westwell AD, Palle K. Bioorg Med Chem Lett; 2016 Apr 15; 26(8):2030-4. PubMed ID: 26965855 [Abstract] [Full Text] [Related]
16. Novel arylpyrazino[2,3-c][1,2,6]thiadiazine 2,2-dioxides as inhibitors of platelet aggregation. 1. Synthesis and pharmacological evaluation. Campillo N, García C, Goya P, Páez JA, Carrasco E, Grau M. J Med Chem; 1999 May 20; 42(10):1698-704. PubMed ID: 10346922 [Abstract] [Full Text] [Related]
17. Synthesis and antitumor activity of benzimidazolyl-1,3,5-triazine and benzimidazolylpyrimidine derivatives. Matsuno T, Karo M, Sasahara H, Watanabe T, Inaba M, Takahashi M, Yaguchi SI, Yoshioka K, Sakato M, Kawashima S. Chem Pharm Bull (Tokyo); 2000 Nov 20; 48(11):1778-81. PubMed ID: 11086914 [Abstract] [Full Text] [Related]
18. Synthesis and platelet aggregation inhibitory activities of 3-(2-oxopropylidene)azetidin-2-one derivatives. II. Kawashima Y, Sato M, Hatada Y, Goto J, Yamane Y, Hatayama K. Chem Pharm Bull (Tokyo); 1991 Dec 20; 39(12):3202-6. PubMed ID: 1814612 [Abstract] [Full Text] [Related]
19. Synthesis and evaluation of coumarin alpha-methylene-gamma-butyrolactones: a new class of platelet aggregation inhibitors. Chen YL, Wang TC, Liang SC, Teng CM, Tzeng CC. Chem Pharm Bull (Tokyo); 1996 Aug 20; 44(8):1591-5. PubMed ID: 8795278 [Abstract] [Full Text] [Related]
20. A general approach toward the synthesis of C-nucleoside pyrazolo[1,5-a]-1,3,5-triazines and their 3',5'-bisphosphate C-nucleotide analogues as the first reported in vivo stable P2Y(1)-receptor antagonists. Raboisson P, Baurand A, Cazenave JP, Gachet C, Schultz D, Spiess B, Bourguignon JJ. J Org Chem; 2002 Nov 15; 67(23):8063-71. PubMed ID: 12423133 [Abstract] [Full Text] [Related] Page: [Next] [New Search]